Zentalis (ZNTL) announced the appointment of James Bucher as chief legal officer and corporate secretary, effective September 18. Andrea Paul, who has served as Zentalis’ chief legal officer and Corporate Secretary since 2022, will be departing the company to join the partnership of a law firm. Most recently, Bucher served as chief legal officer at Harpoon Therapeutics.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZNTL:
- Zentalis price target lowered to $5 from $6 at Wells Fargo
- Strategic Advancements and Promising Clinical Data Support Buy Rating for Zentalis Pharmaceuticals
- Zentalis Pharmaceuticals: Hold Rating Amid Delayed Catalysts and Market Skepticism
- Zentalis Pharmaceuticals Reports Improved Financial Results
- Zentalis Pharmaceuticals Reports Q2 2025 Financial Results